Skip to main content

Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors.

PMID: 35338084
Journal: Journal for ImmunoTherapy of Cancer
Year: 2022
Reference: J Immunother Cancer. 2022 Mar;10(3). pii: jitc-2021-003255. doi: 10.1136/jitc-2021-003255.
Impact factor: 13.751
Publication type: Paper in international publication
Authors: Vidal, Noemi, Garcia-Carbonero, Rocio, Bazan-Peregrino, Miriam, Gil-Martin, Marta, Alvarez, Rafael, Macarulla, Teresa, Riesco-Martinez, Maria C, Verdaguer, Helena, Guillen-Ponce, Carmen, Farrera-Sal, Marti et al.
DOI: 10.1136/jitc-2021-003255

Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors.

PMID: 35338084
Journal: Journal for ImmunoTherapy of Cancer
Year: 2022
Reference: J Immunother Cancer. 2022 Mar;10(3). pii: jitc-2021-003255. doi: 10.1136/jitc-2021-003255.
Impact factor:
Publication type: Paper in international publication
Authors: Alemany, Ramon; Alvarez, Rafael; Bazan-Peregrino, Miriam; Blasco, Carmen; Blasi, Emma; Capella, Gabriel; Cascallo, Manel; Costa, Marcel; Del Pozo, Natalia; Farrera-Sal, Marti et al.
DOI: 10.1136/jitc-2021-003255

Phase I trial of the DLL3/CD3 bispecific T-cell engager BI 764532 in DLL3-positive small-cell lung cancer and neuroendocrine carcinomas.

PMID: 35815644
Journal: Future Oncology
Year: 2022
Reference: Future Oncol. 2022 Aug;18(24):2639-2649. doi: 10.2217/fon-2022-0196. Epub 2022 Jul 11.
Impact factor: 3.404
Publication type: Review in international publication
Authors: Studeny, Matus, Liu, Meiruo, Hamed, Zohra Oum', Morgensztern, Daniel, Kuboki, Yasutoshi, Gambardella, Valentina, Felip, Enriqueta, Wermke, Martin, Owonikoko, Taofeek K et al.
DOI: 10.2217/fon-2022-0196

Phase I trial of the DLL3/CD3 bispecific T-cell engager BI 764532 in DLL3-positive small-cell lung cancer and neuroendocrine carcinomas.

PMID: 35815644
Journal: Future Oncology
Year: 2022
Reference: Future Oncol. 2022 Aug;18(24):2639-2649. doi: 10.2217/fon-2022-0196. Epub 2022 Jul 11.
Impact factor:
Publication type: Review in international publication
Authors: Felip, Enriqueta; Gambardella, Valentina; Hamed, Zohra Oum'; Kuboki, Yasutoshi; Liu, Meiruo; Morgensztern, Daniel; Owonikoko, Taofeek K; Studeny, Matus; Wermke, Martin et al.
DOI: 10.2217/fon-2022-0196

Phase Ib/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non-small cell lung cancer.

PMID: 35298959
Journal: LUNG CANCER
Year: 2022
Reference: Lung Cancer. 2022 Apr;166:170-177. doi: 10.1016/j.lungcan.2022.02.010. Epub 2022 Mar 1.
Impact factor: 5.705
Publication type: Paper in international publication
Authors: Santoro, Armando, Su, Wu-Chou, Simonelli, Matteo, Ch Yang, James, Ardizzoni, Andrea, Barlesi, Fabrice, Hyoung Kang, Jin, DiDominick, Sarah, Abdelhady, Ahmed, Chen, Xueying et al.
DOI: 10.1016/j.lungcan.2022.02.010

Phase Ib/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non-small cell lung cancer.

PMID: 35298959
Journal: LUNG CANCER
Year: 2022
Reference: Lung Cancer. 2022 Apr;166:170-177. doi: 10.1016/j.lungcan.2022.02.010. Epub 2022 Mar 1.
Impact factor:
Publication type: Paper in international publication
Authors: Abdelhady, Ahmed; Ardizzoni, Andrea; Barlesi, Fabrice; Ch Yang, James; Chen, Xueying; DiDominick, Sarah; Felip, Enriqueta; Hyoung Kang, Jin; Navarro, Alejandro; Santoro, Armando et al.
DOI: 10.1016/j.lungcan.2022.02.010

Phase II multicohort study of atezolizumab monotherapy in multiple advanced solid cancers.

PMID: 35305400
Journal: ESMO Open
Year: 2022
Reference: ESMO Open. 2022 Apr;7(2):100419. doi: 10.1016/j.esmoop.2022.100419. Epub 2022 Mar 16.
Impact factor: 6.54
Publication type: Paper in international publication
Authors: Tabernero, J, Andre, F, Blay, J-Y, Bustillos, A, Fear, S, Ganta, S, Jaeger, D, Maio, M, Mileshkin, L, Melero, I et al.
DOI: 10.1016/j.esmoop.2022.100419

Phase II multicohort study of atezolizumab monotherapy in multiple advanced solid cancers.

PMID: 35305400
Journal: ESMO Open
Year: 2022
Reference: ESMO Open. 2022 Apr;7(2):100419. doi: 10.1016/j.esmoop.2022.100419. Epub 2022 Mar 16.
Impact factor:
Publication type: Paper in international publication
Authors: Andre, F; Blay, J-Y; Bustillos, A; Fear, S; Ganta, S; Jaeger, D; Maio, M; Melero, I; Mileshkin, L; Tabernero, J et al.
DOI: 10.1016/j.esmoop.2022.100419

Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO).

PMID: 35257949
Journal: LUNG CANCER
Year: 2022
Reference: Lung Cancer. 2022 Apr;166:107-113. doi: 10.1016/j.lungcan.2022.01.023. Epub 2022 Feb 3.
Impact factor: 5.705
Publication type: Paper in international publication
Authors: Ozguroglu, Mustafa, Rodriguez Abreu, Delvys, Adeniji, Abidemi, Lorence, Robert M, Voccia, Isabelle, Chisamore, Michael J, Riess, Jonathan W, Molinier, Olivier, Madelaine, Jeannick, Kim, Sang-We et al.
DOI: 10.1016/j.lungcan.2022.01.023

Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO).

PMID: 35257949
Journal: LUNG CANCER
Year: 2022
Reference: Lung Cancer. 2022 Apr;166:107-113. doi: 10.1016/j.lungcan.2022.01.023. Epub 2022 Feb 3.
Impact factor:
Publication type: Paper in international publication
Authors: Adeniji, Abidemi; Barlesi, Fabrice; Bennouna, Jaafar; Chisamore, Michael J; Erman, Mustafa; Felip, Enriqueta; Isla, Dolores; Kim, Sang-We; Levy, Benjamin; Lorence, Robert M et al.
DOI: 10.1016/j.lungcan.2022.01.023

Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer.

PMID: 35912190
Journal: Frontiers in Oncology
Year: 2022
Reference: Front Oncol. 2022 Jul 14;12:891886. doi: 10.3389/fonc.2022.891886. eCollection 2022.
Impact factor:
Publication type: Paper in international publication
Authors: Gomez-Iturriaga, Alfonso; Hervas-Moron, Asuncion; Lara, Pedro C; Lozano, Antonio; Maldonado, Xavier; Palacios-Eito, Amalia; Rodriguez-Melcon, Juan I; Sancho, Gemma; Villafranca, Elena et al.
DOI: 10.3389/fonc.2022.891886

Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) +/- anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies.

PMID: 35217575
Journal: Journal for ImmunoTherapy of Cancer
Year: 2022
Reference: J Immunother Cancer. 2022 Feb;10(2). pii: jitc-2021-003776. doi: 10.1136/jitc-2021-003776.
Impact factor: 13.751
Publication type: Paper in international publication
Authors: Carvajal, Richard D, Kyi, Chrisann, Esaki, Taito, Prawira, Amy, Akerley, Wallace, De Braud, Filippo, Hui, Rina, Zhang, Tian, Soo, Ross A, Maur, Michela et al.
DOI: 10.1136/jitc-2021-003776

Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) +/- anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies.

PMID: 35217575
Journal: Journal for ImmunoTherapy of Cancer
Year: 2022
Reference: J Immunother Cancer. 2022 Feb;10(2). pii: jitc-2021-003776. doi: 10.1136/jitc-2021-003776.
Impact factor:
Publication type: Paper in international publication
Authors: Akerley, Wallace; Askoxylakis, Vasileios; Carion, Ana; Carvajal, Richard D; Chowdhury, Niladri Roy; De Braud, Filippo; Deschler-Baier, Barbara; Esaki, Taito; Gusenleitner, Daniel; Hong, David S et al.
DOI: 10.1136/jitc-2021-003776

Phenotypes of idiopathic pulmonary arterial hypertension.

PMID: 36179740
Journal: Lancet Respiratory Medicine
Year: 2022
Reference: Lancet Respir Med. 2022 Oct;10(10):e87. doi: 10.1016/S2213-2600(22)00290-9.
Impact factor:
Publication type: Letter or abstract
Authors: Cruz-Utrilla, Alejandro; Escribano-Subias, Pilar; Lopez-Meseguer, Manuel; Martinez-Menaca, Amaya; Perez-Olivares, Carmen et al.
DOI: 10.1016/S2213-2600(22)00290-9

Phenotyping Type 2 Diabetes in Terms of Myocardial Insulin Resistance and Its Potential Cardiovascular Consequences: A New Strategy Based on (18)F-FDG PET/CT.

PMID: 35055345
Journal: Journal of Personalized Medicine
Year: 2022
Reference: J Pers Med. 2022 Jan 2;12(1). pii: jpm12010030. doi: 10.3390/jpm12010030.
Impact factor: 4.945
Publication type: Paper in international publication
Authors: Herance, Jose Raul, Simo, Rafael, Velasquez, Mayra Alejandra, Paun, Bruno, Garcia-Leon, Daniel, Aparicio, Carolina, Mares, Roso, Simo-Servat, Olga, Castell-Conesa, Joan, Hernandez, Cristina et al.
DOI: 10.3390/jpm12010030

Phenotyping Type 2 Diabetes in Terms of Myocardial Insulin Resistance and Its Potential Cardiovascular Consequences: A New Strategy Based on (18)F-FDG PET/CT.

PMID: 35055345
Journal: Journal of Personalized Medicine
Year: 2022
Reference: J Pers Med. 2022 Jan 2;12(1). pii: jpm12010030. doi: 10.3390/jpm12010030.
Impact factor:
Publication type: Paper in international publication
Authors: Aguade-Bruix, Santiago; Aparicio, Carolina; Castell-Conesa, Joan; Garcia-Leon, Daniel; Herance, Jose Raul; Hernandez, Cristina; Mares, Roso; Paun, Bruno; Simo, Rafael; Simo-Servat, Olga et al.
DOI: 10.3390/jpm12010030

Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A.

PMID: 36477027
Journal: Nature Communications
Year: 2022
Reference: Nat Commun. 2022 Dec 7;13(1):7529. doi: 10.1038/s41467-022-35065-z.
Impact factor:
Publication type: Paper in international publication
Authors: Apala, J V; Bueno, M J; Caleiras, E; Calvo, I; Cejalvo, J M; Colomer, R; Cortes, J; Fustero-Torre, C; Garcia-Saenz, J A; Gil-Gil, M et al.
DOI: 10.1038/s41467-022-35065-z

Pilot hepatitis C micro-elimination strategy in Pakistani migrants in Catalonia through a community intervention.

PMID: 35635535
Journal: LIVER INTERNATIONAL
Year: 2022
Reference: Liver Int. 2022 May 30. doi: 10.1111/liv.15327.
Impact factor: 5.828
Publication type: Paper in international publication
Authors: Martro, Elisa, Ouaarab, Hakima, Saludes, Veronica, Buti, Maria, Trevino, Begona, Roade, Luisa, Egea-Cortes, Laia, Reyes-Urena, Juliana, Not, Anna, Majo, Xavier et al.
DOI: 10.1111/liv.15327

Pilot hepatitis C micro-elimination strategy in Pakistani migrants in Catalonia through a community intervention.

PMID: 35635535
Journal: LIVER INTERNATIONAL
Year: 2022
Reference: Liver Int. 2022 Aug;42(8):1751-1761. doi: 10.1111/liv.15327. Epub 2022 Jun 14.
Impact factor:
Publication type: Paper in international publication
Authors: Buti, Maria; Colom, Joan; Egea-Cortes, Laia; Gomez I Prat, Jordi; Majo, Xavier; Martro, Elisa; Not, Anna; Ouaarab, Hakima; Reyes-Urena, Juliana; Roade, Luisa et al.
DOI: 10.1111/liv.15327

Pilot Study Using Recombinant Antigens r-PROE and r-IGLL1 for the Serodiagnosis of Feather Duvet Lung.

PMID: 35312541
Journal: ARCHIVOS DE BRONCONEUMOLOGIA
Year: 2022
Reference: Arch Bronconeumol. 2022 Jul;58(7):554-560. doi: 10.1016/j.arbres.2021.02.011. Epub 2021 Mar 4.
Impact factor: 4.872
Publication type: Paper in national publication
Authors: Cruz, Maria Jesus; Millon, Laurence; Villar, Ana; Reboux, Gabriel; Morell, Ferran; Rouzet, Adeline et al.
DOI: 10.1016/j.arbres.2021.02.011

Pilot Study Using Recombinant Antigens r-PROE and r-IGLL1 for the Serodiagnosis of Feather Duvet Lung.

PMID: 35312541
Journal: ARCHIVOS DE BRONCONEUMOLOGIA
Year: 2022
Reference: Arch Bronconeumol. 2022 Jul;58(7):554-560. doi: 10.1016/j.arbres.2021.02.011. Epub 2021 Mar 4.
Impact factor:
Publication type: Paper in national publication
Authors: Cruz, Maria Jesus; Millon, Laurence; Morell, Ferran; Reboux, Gabriel; Rouzet, Adeline; Villar, Ana et al.
DOI: 10.1016/j.arbres.2021.02.011

Pineal germinoma in a young adult: A case report.

PMID: 35347869
Journal: Cancer reports (Hoboken, N.J.)
Year: 2022
Reference: Cancer Rep (Hoboken). 2022 Mar 28:e1611. doi: 10.1002/cnr2.1611.
Impact factor: 0
Publication type: Letter or abstract
Authors: Fernandez-Rodriguez, Lissett Jeanette, Maldonado-Pijoan, Xavier et al.
DOI: 10.1002/cnr2.1611

Pineal germinoma in a young adult: A case report.

PMID: 35347869
Journal: Cancer reports (Hoboken, N.J.)
Year: 2022
Reference: Cancer Rep (Hoboken). 2022 Sep;5(9):e1611. doi: 10.1002/cnr2.1611. Epub 2022 Mar 28.
Impact factor:
Publication type: Letter or abstract
Authors: Fernandez-Rodriguez, Lissett Jeanette; Maldonado-Pijoan, Xavier et al.
DOI: 10.1002/cnr2.1611

PirePred: An Accurate Online Consensus Tool to Interpret Newborn Screening Related Genetic Variants in Structural Context.

PMID: 35143952
Journal: JOURNAL OF MOLECULAR DIAGNOSTICS
Year: 2022
Reference: J Mol Diagn. 2022 Apr;24(4):406-425. doi: 10.1016/j.jmoldx.2022.01.005. Epub 2022 Feb 7.
Impact factor: 5.568
Publication type: Paper in international publication
Authors: Galano-Frutos, Juan Jose; Garcia-Cebollada, Helena; Lopez, Alfonso; Rosell, Mireia; Cruz, Xavier de la; Fernandez-Recio, Juan; Sancho, Javier et al.
DOI: 10.1016/j.jmoldx.2022.01.005